ZYDUS PHARMS USA INC FDA Approval ANDA 213984

ANDA 213984

ZYDUS PHARMS USA INC

FDA Drug Application

Application #213984

Documents

Letter2022-01-12

Application Sponsors

ANDA 213984ZYDUS PHARMS USA INC

Marketing Status

None (Tentative Approval)001
Prescription002
Prescription003
Prescription004

Application Products

001CAPSULE;ORALEQ 1.5MG BASE0CARIPRAZINE HYDROCHLORIDECARIPRAZINE HYDROCHLORIDE
002CAPSULE;ORALEQ 3MG BASE0CARIPRAZINE HYDROCHLORIDECARIPRAZINE HYDROCHLORIDE
003CAPSULE;ORALEQ 4.5MG BASE0CARIPRAZINE HYDROCHLORIDECARIPRAZINE HYDROCHLORIDE
004CAPSULE;ORALEQ 6MG BASE0CARIPRAZINE HYDROCHLORIDECARIPRAZINE HYDROCHLORIDE

FDA Submissions

UNKNOWN; ORIG1TA2021-12-07STANDARD

Submissions Property Types

ORIG1Null31

TE Codes

001PrescriptionAB
002PrescriptionAB
003PrescriptionAB
004PrescriptionAB

CDER Filings

ZYDUS PHARMS USA INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 213984
            [companyName] => ZYDUS PHARMS USA INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"CARIPRAZINE","activeIngredients":"CARIPRAZINE","strength":"UNKNOWN","dosageForm":"UNKNOWN","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"12\/07\/2021","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2021-12-07
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.